Insider Selling Continues for Verisk Analytics’ CFO
Elizabeth Mann, the Chief Financial Officer of Verisk Analytics, has sold an additional 400 shares on October 15, 2026, under a 10b‑5 plan she established in December 2025. The transaction was executed at $184.85 per share, leaving her with 17,584 shares—roughly 0.07 % of the outstanding equity. It is the 15th consecutive monthly sale in a streak that began in July 2026, following a pattern of monthly 400‑share divestitures that have been fairly consistent in size and price.
The recent sale comes at a time when the stock has rallied 7.5 % over the past week and 5 % over the month, yet the company is still 18.9 % off its year‑high. From an investor’s viewpoint, the steady selling cadence could signal that the CFO is systematically rebalancing her portfolio rather than reacting to short‑term market noise. The 10b‑5 plan structure also suggests a long‑term horizon for the distribution of proceeds, reducing concerns that she is liquidating in response to any negative corporate news. However, the timing—just after a 3‑point uptick in social‑media sentiment and a 40 % buzz spike—raises the question of whether she is preempting a potential market dip that is already being discussed online.
For the broader market, the pattern of insider selling has not yet eroded confidence. Verisk’s fundamentals remain solid: a $23.5 billion market cap, a 27.75 price‑earnings ratio that sits comfortably above the industry average, and a stable revenue stream from its risk‑analytics platform. Yet, the CFO’s repeated monthly sales, combined with the company’s recent volatility in the 52‑week range, could pressure the stock if the trend continues and investor sentiment turns negative. Analysts will watch whether the CFO’s selling pace accelerates or slows—especially as the company approaches its next earnings cycle.
Who Is Elizabeth Mann?
Elizabeth Mann entered Verisk’s executive ranks in 2021 and has been a frequent filer since 2025. Her transaction history shows a mix of large purchases in January 2026—acquiring 7,808 shares for cash and 3,152 shares for stock options—and a steady stream of 400‑share sales that have spanned from May 2025 through October 2026. She also sold a 300‑share block in December 2025 at $219.54, and a 300‑share block in October 2025 at $242.23, both at premium prices relative to the closing levels that month. These data suggest that Mann typically sells when the stock is near or above her entry price, and she appears to use 10b‑5 plans to manage tax implications. Her trading volume is modest compared to other senior officers (e.g., Shavel Lee’s large block trades) but consistent enough to indicate a disciplined approach to personal wealth management.
Implications for Investors
For shareholders, the CFO’s disciplined selling may reinforce the notion that the company’s insiders are not in a scramble to liquidate in the face of adverse fundamentals. Instead, they are likely rebalancing portfolios or harvesting gains in a methodical way. Nonetheless, the pattern of regular monthly sales—if it persists—could be a subtle cue that insiders are not fully convinced of a sustained upside, especially in a sector that has seen heightened regulatory scrutiny and pricing pressure in the insurance analytics space. Investors should consider whether the CFO’s exit strategy aligns with the company’s long‑term growth prospects, particularly as Verisk looks to expand its predictive‑analytics offerings into new markets. Maintaining a watchful eye on insider activity, alongside quarterly earnings and regulatory developments, will be key to evaluating whether the current sales trend signals a benign portfolio adjustment or a harbinger of more significant divestitures ahead.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026-10-15 | Mann Elizabeth (Chief Financial Officer) | Sell | 400.00 | 184.85 | Common Stock |
